Author

A. D. Rodriguez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Microbiology· 2 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:Arabidopsis· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Folch· 2 shared K. Castro· 2 shared L. F. Horowitz· 2 shared R. C. Rostomily· 2 shared R. J. Monnat· 2 shared W. C. Black· 2 shared A. I. O. Morales· 1 shared A. Lopez-Solis· 1 shared

Activity by Year

2017-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. Folch

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Pyrethroid susceptibility reversal in Aedes aegypti: a longitudinal study in Tapachula, Mexico

P. Penilla-Navarro, F. Solis-Santoyo, A. Lopez-Solis, A. D. Rodriguez, F. Vera-Maloof, S. Lozano, E. Contreras-Mejia, G. Vazquez-Samayoa, R. Torreblanca-Lopez, R. Perera, W. C. Black, K. Saavedra-Rodriguez

This study shows that stopping pyrethroid use in mosquitoes reduced their resistance over time, but resistance rebounded when pyrethroids were reintroduced.

bioRxiv · May 11, 2023 · PreprintEvolutionary Biology

A Microfluidic Platform for Functional Testing of Cancer Drugs on Intact Tumor Slices

A. D. Rodriguez, L. F. Horowitz, K. Castro, H. Kenerson, N. Bhattacharjee, G. Gandhe, A. Raman, R. J. Monnat, R. S. Yeung, R. C. Rostomily, A. Folch

This paper develops a microfluidic platform for testing cancer drugs on intact tumor slices to improve drug response assessment in precision oncology.

bioRxiv · Mar 2, 2020Bioengineering

Multiplexed drug testing of tumor slices using a microfluidic platform

L. F. Horowitz, A. D. Rodriguez, Z. Dereli-Korkut, R. Lin, K. Castro, A. Mikheev, R. J. Monnat, A. Folch, R. C. Rostomily

This paper develops a microfluidic platform for rapid, multiplexed drug testing of cancer slices to guide personalized therapy.

bioRxiv · Feb 25, 2020Bioengineering

A reverse-transcription/RNase H based protocol for depletion of mosquito ribosomal RNA facilitates viral intrahost evolution analysis, transcriptomics and pathogen discovery.

J. R. Fauver, S. Akter, A. I. O. Morales, W. C. Black, A. D. Rodriguez, M. D. Stenglein, G. D. Ebel, J. Weger-Lucarelli

This paper introduces a reverse-transcription/RNase H protocol to deplete mosquito rRNA, enabling efficient viral analysis and discovery in field samples.

bioRxiv · Oct 26, 2018Microbiology

Estimating the effects of variation in viremia on mosquito susceptibility, infectiousness, and R0 of Zika in Aedes aegypti

B. Tesla, L. R. Demakovsky, H. S. Packiam, E. A. Mordecai, A. D. Rodriguez, M. H. Bonds, M. A. Brindley, C. C. Murdock

This study examines how varying ZIKV viremia levels affect mosquito infection, infectiousness, and R0, finding increased infection and infectiousness with higher doses but no effect on dissemination or mortality.

bioRxiv · Nov 17, 2017Microbiology